These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10662107)

  • 1. An Alzheimer's advance.
    Cowley G
    Newsweek; 1999 Nov; 134(18):76. PubMed ID: 10662107
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular amyloid-beta in Alzheimer's disease.
    LaFerla FM; Green KN; Oddo S
    Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.
    Luo Y; Bolon B; Kahn S; Bennett BD; Babu-Khan S; Denis P; Fan W; Kha H; Zhang J; Gong Y; Martin L; Louis JC; Yan Q; Richards WG; Citron M; Vassar R
    Nat Neurosci; 2001 Mar; 4(3):231-2. PubMed ID: 11224535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
    Sheng SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorated plaques in Alzheimer's disease.
    Tabira T
    Ann Neurol; 2009 Jan; 65(1):4-6. PubMed ID: 19194874
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer's disease.
    Bibl M; Esselmann H; Mollenhauer B; Wiltfang J
    Neuroscience; 2007 Apr; 146(1):17-8. PubMed ID: 17317020
    [No Abstract]   [Full Text] [Related]  

  • 9. The bad seed in Alzheimer's disease.
    Fryer JD; Holtzman DM
    Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
    Sparks DL; Martin TA; Gross DR; Hunsaker JC
    Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-amyloid: friend or foe.
    Campbell A
    Med Hypotheses; 2001 Mar; 56(3):388-91. PubMed ID: 11359367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology: Alzheimer's in real time.
    Masliah E
    Nature; 2008 Feb; 451(7179):638-9. PubMed ID: 18256653
    [No Abstract]   [Full Text] [Related]  

  • 14. Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain.
    Siegel DA; Davies P; Dobrenis K; Huang M
    J Neurochem; 2006 Jul; 98(1):34-44. PubMed ID: 16805794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease. Plaque removers and shakers.
    Heemels MT
    Nature; 2000 Aug; 406(6795):465. PubMed ID: 10970202
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's disease. Play and exercise protect mouse brain from amyloid buildup.
    Marx J
    Science; 2005 Mar; 307(5715):1547. PubMed ID: 15761131
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.